X @Bloomberg
Bloomberg·2026-03-16 01:51
Novo Nordisk's patent on semaglutide, the active ingredient in Ozempic and Wegovy that reshaped the global weight-loss industry, expires in India on March 20. At least five Indian drugmakers are readying to sell cheaper copies of the drug. https://t.co/7X6Slgbiia ...